5FA-29554-25356
3 vaccinations
2 coded responses
35 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 539 / WI
- Registered
- 2022-11-19
- Relationship
- Child or adolescent in my care
- Guardian
- K7J-14451-57825
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-11-17
Dose 1 — Pfizer-BioNTech
-
2022-11-19
Registered in v-safe
- 2022-11-19
- 2022-11-20
- 2022-11-21
- 2022-11-22
- 2022-11-23
- 2022-11-26
- 2022-12-01
- 2022-12-08
- 2022-12-15
-
2022-12-21
Dose 2 — Pfizer-BioNTech
- 2022-12-21
- 2022-12-22
- 2022-12-23
- 2022-12-24
- 2022-12-25
- 2022-12-26
- 2022-12-27
- 2022-12-29
-
2023-01-04
Survey response — day 14, dose 2, dependentMedDRA: Cough, Nasal congestion, Nasopharyngitis, Sneezing — Feeling: FairMedDRA releases: 2024-11
- 2023-01-11
-
2023-01-18
Survey response — day 28, dose 2, dependentMedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-18
Report sent to call center — day 28, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-01-25
- 2023-02-01
- 2023-03-22
-
2023-03-29
Dose 3 — Pfizer-BioNTech
-
2023-03-30
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2023-03-31
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2023-04-01
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2023-04-03
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2023-04-04
- 2023-04-05
- 2023-04-12
- 2023-04-19
- 2023-04-26
- 2023-05-03
- 2023-05-10
- 2023-06-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-11-17 | Pfizer-BioNTech | No |
| 2 | 2022-12-21 | Pfizer-BioNTech | No |
| 3 | 2023-03-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release